prescription drugs / drug prices Archives - ACHP

ACHP Statement on CY2026 Medicare Advantage and Part D Rate Notice

We are pleased that CMS is anticipating a new risk-adjustment model calibrated on MA encounter data, reflected in our MA for Tomorrow initiative.

ACHP Letter to Trump HHS Transition Team

ACHP sent a letter to the Trump HHS Transition Team outlining policy priorities for community health plans in 2025

Americans Expect Congress to Pass Critical Health Care Provisions

ACHP commends Congressional leaders for including critical health care provisions in this week’s continuing resolution to fund the government through March 14, 2025. The bill makes health care more competitive and affordable at a time when voters are clamoring for relief.

ACHP Statement on CY2026 MA & Part D Rule

ACHP released a statement on the Medicare Advantage and Part D Proposed Rule for Contract Year 2026.

Looking Ahead: ACHP’s Policy Priorities Under the Incoming Trump Administration

ACHP will continue to prioritize public health and improve health care quality, accessibility and affordability by working with the incoming Trump Administration and 119th Congress in 2025 and beyond.

Making Health Care Better

ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.

Stay Connected